CA2151702C - Quick connect medication delivery pen - Google Patents
Quick connect medication delivery penInfo
- Publication number
- CA2151702C CA2151702C CA002151702A CA2151702A CA2151702C CA 2151702 C CA2151702 C CA 2151702C CA 002151702 A CA002151702 A CA 002151702A CA 2151702 A CA2151702 A CA 2151702A CA 2151702 C CA2151702 C CA 2151702C
- Authority
- CA
- Canada
- Prior art keywords
- assembly
- lead screw
- cartridge
- housing
- medication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
- A61M5/31585—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod performed by axially moving actuator, e.g. an injection button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
- A61M5/31551—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe including axial movement of dose setting member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
- A61M5/31543—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose piston rod reset means, i.e. means for causing or facilitating retraction of piston rod to its starting position during cartridge change
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/31556—Accuracy improving means
- A61M5/31558—Accuracy improving means using scaling up or down transmissions, e.g. gearbox
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/31561—Mechanically operated dose setting member using freely adjustable volume steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/3159—Dose expelling manners
- A61M5/31593—Multi-dose, i.e. individually set dose repeatedly administered from the same medicament reservoir
Abstract
A medication delivery pen is provided having a reusable pen body assembly and a disposable cartridge assembly that are threadedly engageable with one another. The disposable cartridge assembly includes a plunger and can releasably receive a needle cannula assembly. A portion of the pen body assembly projects into the cartridgeholder assembly for driving the cartridge plunger distances that are selected inaccordance with a desired dose of medication to be delivered. The cartridge holder assembly can be disassembled from the pen body assembly after the medication therein has been exhausted, and the used cartridge holder assembly may be discarded and replaced.
Description
a_ / .
21y7~Z~~
s BACKGROUND OF THE INVENTION
Io 1. held of the Invention is The subject invention relates to medication delivery pens having a disposable cartridge holder assembly and a reusable pen body assembly removably mounted to the cartridge holder assembly for delivering selected doses of medication.
20 2. Description of Related Art Hypodermic syringes are used to deliver selected doses of medication to patients. The prior art hypodermic syringe includes a syringe barrel having opposed proximal and distal ends. A cylindrical chamber wall extends between the ends and 25 defines a fluid receiving chamber. The proximal end of the prior art syringe barrel is substantially open and receives a plunger in sliding fluid tight engagement.
The distal end of the prior art syringe barrel includes a passage communicating with the chamber.
A
~~ ~2 7~~
A needle cannula may be mounted to the distal end of the prior art syringe barrel, such that the lumen of the needle cannula communicates with the passage and the chamber of the syringe barrel. Movement of the plunger in a proximal direction draws fluid through the lumen of the needle cannula and into the chamber. Movement of the plunger in a proximal-to-distal direction urges fluid from the chamber and through the lumen of the needle cannula.
Medication to be injected with the prior art hypodermic syringe often is stored in a vial having a pierceable elastomeric seal. Medication in the prior art vial is to accessed by piercing the elastomeric seal with the needle cannula. A
selected dose of the medication may be drawn into the chamber of the syringe barrel by moving the plunger a selected distance in a proximal direction. The needle cannula may be withdrawn from the vial, and the medication may be injected into a patient by moving the plunger in a distal direction.
Some medication, such as insulin is self administered. The typical diabetes patient will require injections of insulin several times during the course of the day. The required dose of insulin will vary from patient to patient, and for each patient may vary during the course of the day and from day to day. Each diabetes patient will establish a 2o regimen that is appropriate for his or her own medical condition and for his or her lifestyle. The regimen typically includes some combination of a slow or medium acting insulin and a faster acting insulin. Each of these regimens may require the diabetes patient to periodically self administer insulin in public locations, such as places of employment or restaurants. The required manipulation of the standard prior art hypodermic syringe and vial can be inconvenient and embarrassing in these public environments.
21y7~Z~~
s BACKGROUND OF THE INVENTION
Io 1. held of the Invention is The subject invention relates to medication delivery pens having a disposable cartridge holder assembly and a reusable pen body assembly removably mounted to the cartridge holder assembly for delivering selected doses of medication.
20 2. Description of Related Art Hypodermic syringes are used to deliver selected doses of medication to patients. The prior art hypodermic syringe includes a syringe barrel having opposed proximal and distal ends. A cylindrical chamber wall extends between the ends and 25 defines a fluid receiving chamber. The proximal end of the prior art syringe barrel is substantially open and receives a plunger in sliding fluid tight engagement.
The distal end of the prior art syringe barrel includes a passage communicating with the chamber.
A
~~ ~2 7~~
A needle cannula may be mounted to the distal end of the prior art syringe barrel, such that the lumen of the needle cannula communicates with the passage and the chamber of the syringe barrel. Movement of the plunger in a proximal direction draws fluid through the lumen of the needle cannula and into the chamber. Movement of the plunger in a proximal-to-distal direction urges fluid from the chamber and through the lumen of the needle cannula.
Medication to be injected with the prior art hypodermic syringe often is stored in a vial having a pierceable elastomeric seal. Medication in the prior art vial is to accessed by piercing the elastomeric seal with the needle cannula. A
selected dose of the medication may be drawn into the chamber of the syringe barrel by moving the plunger a selected distance in a proximal direction. The needle cannula may be withdrawn from the vial, and the medication may be injected into a patient by moving the plunger in a distal direction.
Some medication, such as insulin is self administered. The typical diabetes patient will require injections of insulin several times during the course of the day. The required dose of insulin will vary from patient to patient, and for each patient may vary during the course of the day and from day to day. Each diabetes patient will establish a 2o regimen that is appropriate for his or her own medical condition and for his or her lifestyle. The regimen typically includes some combination of a slow or medium acting insulin and a faster acting insulin. Each of these regimens may require the diabetes patient to periodically self administer insulin in public locations, such as places of employment or restaurants. The required manipulation of the standard prior art hypodermic syringe and vial can be inconvenient and embarrassing in these public environments.
2~ ~.~ Q02 Medication delivery pens have been developed to facilitate the self administration of medication. One prior arr medication delivery pen includes a vial holder into which a vial of insulin or other medication may be received. The vial holder is an elongate generally tubular structure with proximal and distal ends. The distal end of the prior art vial holder includes mounting means for engaging a double-ended needle cannula. The proximal end also includes mounting means for engaging a driver and dose setting apparatus as explained further below. A disposable vial for use with the prior art vial holder includes a distal end having a pierceable elastomeric seal to that can be pierced by one end of a double-ended needle cannula. The proximal end of this prior art vial includes a plunger slidably disposed in fluid tight engagement with the cylindrical wall of the vial. This prior art medication delivery pen is used by inserting the vial of medication into the vial holder. A prior art pen body then is connected to the proximal end of the vial holder. The pen body includes a dose setting ~5 apparatus for designating a dose of medication to be delivered by the pen and a driving apparatus for urging the plunger of the vial distally for a distance corresponding to the selected dose.
The user of the pen mounts a prior art double-ended needle cannula to the distal 2o end of the vial holder such that the proximal point of the needle cannula pierces the elastomeric seal on the vial. The patient then selects a dose and operates the pen to urge the plunger distally to deliver the selected dose. The dose selecting apparatus returns to zero upon injection of the selected dose with this prior art medication delivery pen. The patient then removes and discards the needle cannula, and keeps the 25 prior art medication delivery pen in a convenient location for the next required medication administration. The medication in the vial will become exhausted after ~~ ~1 Q02 several such administrations of medication. The patient then separates the vial holder from the pen body. The empty vial may then be removed and discarded. A new vial can be inserted into the vial holder, and the vial holder and pen body can be reassembled and used as explained above.
The above described reusable medication delivery pen is effective and much more convenient for self administration of medication than the typical hypodermic syringe and separate medication vial. However, the disassembly of the pen to remove empty medication vials and to insert new ones is an inconvenience. As a result, disposable pens have been developed. The prior art disposable medication delivery pen includes a vial of insulin or other such medication permanently encapsulated therein.
The patient need merely connect a double-ended needle cannula to the disposable pen for each administration of medication. The prior art disposable pen can be discarded when the supply of medication permanently encapsulated therein has been exhausted.
is Disposable medication delivery pens offer certain conveniences to the patient who is required to self administer medication. However, the dose selecting and driving mechanisms of prior art medication delivery pens are fairly complex devices that are costly to manufacture. Hence, a substantial cost penalty is associated with the 2o convenience of using a disposable medication delivery pen.
SUMMARY OF THE INVENTION
The subject invention relates to a medication delivery pen having a disposable 25 medication cartridge assembly that is selectively engageable with and disengageable from a reusable pen body assembly. The disposable medication cartridge assembly is ~~~.~ Q02 an elongate generally cylindrical structure having opposed proximal and distal ends.
The distal end of the disposable medication cartridge assembly includes needle mounting means for securely but releasably receiving a needle cannula assembly. The distal end may be characterized by a pierceable elastomeric seal that may be repeatedly and resealable pierced by the proximal end of a double-ended needle cannula.
The proximal end of the disposable medication cartridge assembly includes body mounting means for securely but releasably mounting the disposable medication cartridge assembly to the reusable pen body assembly. The body mounting means may comprise an array of threads extending distally from the proximal end of the disposable medication cartridge assembly.
The disposable medication cartridge assembly further includes plunger means slidably disposed in fluid tight engagement therein. The plunger means may initially be disposed in a proximal position within the medication cartridge assembly and may be ~5 moved in a distal direction by a driver projecting from the pen body assembly. The disposable medication cartridge assembly further comprise anti-rotation means for preventing rotation of the driver.
The reusable pen body assembly of the subject invention comprises an array of 2o mounting threads to enable threaded engagement of the reusable pen body assembly and the disposable medication cartridge assembly. An actuator button may be rotatably mounted on the proximal end of the pen body assembly. Thus, axial forces exerted on the actuator button will cause the pen body assembly to threadedly engage the disposable medication cartridge assembly.
The pen body assembly further includes a lead screw for selectively engaging .._ ~~~~~02 the plunger of the disposable cartridge assembly and for urging the plunger of the disposable cartridge assembly in a distal direction. At least a portion of the Iead screw may have driving threads engaged with other portions of the pen body assembly.
This threaded engagement may be operative to achieve axial movement of the Lead screw in s response to axial forces exerted on the rotatable actuator button. The driving threads may define the same pitch and the same direction of generation as the mounting threads of the pen body assembly. As will be explained in greater detail below, this feature of the medication delivery pen facilitates the quick connection of the pen body assembly to the disposable medication cartridge assembly, and further assures a virtually automatic io return of the lead screw to a start position each time a new disposable medication cartridge assembly is mounted to the pen body assembly. The lead screw may further be engageable with the anti-rotation means of the disposable cartridge assembly. Thus, relative rotation between the lead screw means and the disposable cartridge assembly is substantially prevented.
~5 The pen body assembly further comprises a dose setting means for establishing and precisely controlling the amount of medication to be delivered in response to each actuation of the actuator button. The dose setting means may be any of several structures as described in greater detail below.
A disposable cartridge assembly that is filled with medication may be mounted to the pen body assembly by merely aligning the lead screw with the proximal end of the disposable cartridge assembly and exerting an axial force on the rotatable actuator button. The initial response to forces on the actuator button will cause the lead screw to move in a proximal direction toward its starting position, while the remaining portions of the pen body assembly move distally toward the disposable vial assembly.
The user of the pen mounts a prior art double-ended needle cannula to the distal 2o end of the vial holder such that the proximal point of the needle cannula pierces the elastomeric seal on the vial. The patient then selects a dose and operates the pen to urge the plunger distally to deliver the selected dose. The dose selecting apparatus returns to zero upon injection of the selected dose with this prior art medication delivery pen. The patient then removes and discards the needle cannula, and keeps the 25 prior art medication delivery pen in a convenient location for the next required medication administration. The medication in the vial will become exhausted after ~~ ~1 Q02 several such administrations of medication. The patient then separates the vial holder from the pen body. The empty vial may then be removed and discarded. A new vial can be inserted into the vial holder, and the vial holder and pen body can be reassembled and used as explained above.
The above described reusable medication delivery pen is effective and much more convenient for self administration of medication than the typical hypodermic syringe and separate medication vial. However, the disassembly of the pen to remove empty medication vials and to insert new ones is an inconvenience. As a result, disposable pens have been developed. The prior art disposable medication delivery pen includes a vial of insulin or other such medication permanently encapsulated therein.
The patient need merely connect a double-ended needle cannula to the disposable pen for each administration of medication. The prior art disposable pen can be discarded when the supply of medication permanently encapsulated therein has been exhausted.
is Disposable medication delivery pens offer certain conveniences to the patient who is required to self administer medication. However, the dose selecting and driving mechanisms of prior art medication delivery pens are fairly complex devices that are costly to manufacture. Hence, a substantial cost penalty is associated with the 2o convenience of using a disposable medication delivery pen.
SUMMARY OF THE INVENTION
The subject invention relates to a medication delivery pen having a disposable 25 medication cartridge assembly that is selectively engageable with and disengageable from a reusable pen body assembly. The disposable medication cartridge assembly is ~~~.~ Q02 an elongate generally cylindrical structure having opposed proximal and distal ends.
The distal end of the disposable medication cartridge assembly includes needle mounting means for securely but releasably receiving a needle cannula assembly. The distal end may be characterized by a pierceable elastomeric seal that may be repeatedly and resealable pierced by the proximal end of a double-ended needle cannula.
The proximal end of the disposable medication cartridge assembly includes body mounting means for securely but releasably mounting the disposable medication cartridge assembly to the reusable pen body assembly. The body mounting means may comprise an array of threads extending distally from the proximal end of the disposable medication cartridge assembly.
The disposable medication cartridge assembly further includes plunger means slidably disposed in fluid tight engagement therein. The plunger means may initially be disposed in a proximal position within the medication cartridge assembly and may be ~5 moved in a distal direction by a driver projecting from the pen body assembly. The disposable medication cartridge assembly further comprise anti-rotation means for preventing rotation of the driver.
The reusable pen body assembly of the subject invention comprises an array of 2o mounting threads to enable threaded engagement of the reusable pen body assembly and the disposable medication cartridge assembly. An actuator button may be rotatably mounted on the proximal end of the pen body assembly. Thus, axial forces exerted on the actuator button will cause the pen body assembly to threadedly engage the disposable medication cartridge assembly.
The pen body assembly further includes a lead screw for selectively engaging .._ ~~~~~02 the plunger of the disposable cartridge assembly and for urging the plunger of the disposable cartridge assembly in a distal direction. At least a portion of the Iead screw may have driving threads engaged with other portions of the pen body assembly.
This threaded engagement may be operative to achieve axial movement of the Lead screw in s response to axial forces exerted on the rotatable actuator button. The driving threads may define the same pitch and the same direction of generation as the mounting threads of the pen body assembly. As will be explained in greater detail below, this feature of the medication delivery pen facilitates the quick connection of the pen body assembly to the disposable medication cartridge assembly, and further assures a virtually automatic io return of the lead screw to a start position each time a new disposable medication cartridge assembly is mounted to the pen body assembly. The lead screw may further be engageable with the anti-rotation means of the disposable cartridge assembly. Thus, relative rotation between the lead screw means and the disposable cartridge assembly is substantially prevented.
~5 The pen body assembly further comprises a dose setting means for establishing and precisely controlling the amount of medication to be delivered in response to each actuation of the actuator button. The dose setting means may be any of several structures as described in greater detail below.
A disposable cartridge assembly that is filled with medication may be mounted to the pen body assembly by merely aligning the lead screw with the proximal end of the disposable cartridge assembly and exerting an axial force on the rotatable actuator button. The initial response to forces on the actuator button will cause the lead screw to move in a proximal direction toward its starting position, while the remaining portions of the pen body assembly move distally toward the disposable vial assembly.
z~ 5~ ~o~
Further forces exerted on the actuator button will cause the mounting means of the pen body to engage the mounting means of the disposable cartridge assembly.
Continued axial forces on the actuator will cause the mounting threads to engage the disposable cartridge assembly and will continue the proximal movement of the driver. The pen s body assembly will be fully but releasably engaged with the disposable cartridge assembly at the same time that the driver is at its proximal extreme position and in condition to begin delivering selected doses of medication from the pen. Doses of medication can be dispensed as needed over time. The disposable cartridge assembly can be removed and discarded when the medication therein has been exhausted, and a to new disposable medication cartridge assembly may be mounted to the pen body assembly as described above.
DESCRIPTION OF THE DRAWINGS
~s Fig. 1 is an exploded perspective view of the medication delivery pen of the subject invention.
Fig. 2 is an exploded perspective view of the pen body assembly of the medication delivery pen shown in Fig. 1.
Fig. 3 is an end view of the housing of the pen body assembly.
zo Fig. 4 is a cross-sectional view of the nut taken along line 4-4 in Fig. 2.
Fig. S is a cross-sectional view of the insert taken along line 5-S in Fig. 2.
Fig. 6 is an end elevational view of the cartridge holder assembly.
Fig. 7 is a longitudinal cross-sectional view of the pen in a first partly assembled condition.
2s Fig. 8 is a cross-sectional view similar to Fig. 7, and showing the pen in a second partly assembled condition.
~- ~~51 ~0~
Fig. 9 is a cross-sectional view similar to Figs. 7 and 8, and showing the pen in a fully assembled condition.
Fig. 10 is a cross-sectional view similar to Fig. 9, and showing the assembled pen in condition to deliver a selected dose of medication.
s Fig. 11 is a cross-sectional view similar to Fig. 10 and showing the pen after delivery of the selected dose.
Fig. 12 is an exploded perspective view of an alternative embodiment of a medication delivery pen of the subject invention.
Fig. 13 is an end elevational view of the cartridge assembly in the medication io delivery pen shown in Fig. 12.
DETAILED DESCRIPTION
A medication delivery pen in accordance with the subject invention is identified is generally by the numeral 10 in Figs. 1 and 7-11. Medication delivery pen 10 includes a reusable pen body assembly 12, a disposable cartridge assembly 14, a needle cannula assembly 16 and a cap 17. Cartridge assembly 14 includes opposed proximal and distal ends 18 and 20 respectively. Proximal end 18 of cartridge assembly 14 is dimensioned and configured to threadedly engage pen body assembly 12, as explained further zo herein. Distal end 20 of cartridge assembly 14 is configured to securely but releasably engage needle cannula assembly 16.
The preferred embodiment of reusable pen body assembly 12 is illustrated in greater detail in Fig. 2. It is understood, however, that variations from this preferred 25 embodiment may be provided, and are considered to be within the scope of the subject invention. Reusable pen body assembly 12 includes a generally cylindrical housing 22 _g_ ~Z ~~ Q02 having opposed proximal and distal ends 24 and 26, and a substantially hollow throughbore 28 extending axially therethrough. An array of external threads 30 extends proximally from distal end 26 for threaded engagement with proximal end 18 of cartridge holder assembly 14. Portions of hollow throughbore 28 of housing adjacent distal end 26 are characterized by an array of clutch teeth 32, shown in Fig. 3, molded therein. Proximal end 24 of housing 22 is characterized by a cut-out 33 formed therein for receiving a window insert 78, as shown in Fig. 5 and explained further herein.
1o Pen body assembly 12 further includes a nut 34 having opposed proximal and distal ends 36 and 38 respectively. Exterior surface regions of nut 34 between proximal and distal ends 36 and 38, shown in Fig. 4, define a plurality of longitudinally extending splines 39. Proximal end 36 of nut 34 is characterized by a plurality of longitudinally extending resilient fingers 40 with enlarged ends that enable ~5 snap engagement of nut 34 into other portions of pen body assembly 12 as explained further herein. Distal end 38 of nut 34 is radially enlarged to limit axial movement of nut 34 into distal end 26 of housing 22. Thus, nut 34 is axially constrained within housing 22. However, the dimensions and configurations of nut 34 and housing permit free relative rotation therebetween.
Pen body assembly 12 further includes a clutch assembly 42 mounted therein.
Clutch assembly 42 includes a proximal clutch 44, a distal clutch 46 and an annular spring 48 biasingly engaged therebetween. Proximal and distal clutches 44 and 46 each are configured for non-rotatable engagement over splines 39 of nut 34. Distal clutch 46 includes an array of distally facing saw teeth dimensioned, disposed and configured for engagement with teeth 32, shown in Fig. 3, on the interior of housing 22, such that ~~ ~~ Q02 distal clutch 46 can rotate only in one direction relative to housing 22.
Proximal clutch 44 includes an array of proximally facing teeth which are also co~gured for unidirectional rotation as explained further herein.
Pen body assembly 12 further includes a generally cylindrical driver 50 having opposed proximal and distal ends 52 and 54. Driver 50 is slidably inserted into housing 22 of pen body assembly 12 such that distal end 54 of driver 50 is snap fit over the enlarged ends of resilient forgers 40 at proximal end 36 of nut 34. This snap fit engagement prevents axial movement between nut 34 and driver 50, but permits free 1o relative rotational movement within housing 22. Distal end 54 of driver 50 is also characterized by an array of saw teeth 49 that engage with the saw teeth on proximal clutch 44. Outer surface regions of driver 50 are characterized by splines 56 extending radially outwardly thereon and along a substantial portion of the length of driver 50.
t5 Pen body assembly 12 further includes a dose, knob 58 which is a hollow generally cylindrical structure having opposed proximal and distal ends 60 and 62 and opposed inner and outer surfaces 64 and 66. Inner surface 64 is characterized by longitudinally extending grooves 68 which are disposed and dimensioned for engagement with splines 56 on driver 50. More particularly, dose knob 58 is spline 2o mounted over driver 50 within housing 22 of pen body assembly 12. Thus, axially extending grooves 68 in dose knob 58 engage splines 56 of driver 50 to prevent relative rotation therebetween, but permitting relative axial movement. Outer surface 66 of dose knob 58 is characterized by a groove 70 that includes a linear component 72 and a helical component 74, which connects opposed ends of linear component 72.
Portions 25 of outer surface 66 adjacent helical component 74 of groove 70 are provided with dosage indicia to define dose amounts corresponding to different positions along groove 2~ ~Z Q02 70 as explained further herein. Proximal end 60 of dose knob S 8 is characterized by a gnarled exterior surface to facilitate manipulation for setting a selected dose. An actuator button 76 is snapped in to engagement with proximal end 60 of dose knob 58 to permit relative rotation therebetween.
An insert 78, shown in Figs. 2 and S, is snapped into engagement with cut-out 33 in the proximal end 24 of housing 22. Insert 78 includes opposed inner and outer surfaces 80 and 82 and a window 84 extending therebetween. Inner surface 80 of insert 78 includes a button 86 on an interior face which is dimensioned and disposed to io engage in groove 70 of dose knob 58. Button 86 and window 84 are disposed to enable the indicia on dose knob 58 to be visible through window 84.
Pen body assembly 12 further includes a lead screw 88 with opposed proximal and distal ends 90 and 92 and an array of external threads 94. External threads 94 are ~5 characterized, however, by a pair of opposed axially extending grooves 96 which extend from distal end 92 substantially to the proximal end 90. Threads 94 are engaged in nut 34, such that proximal end 90 of lead screw 88 is within housing 22 and distal end 92 projects distally beyond housing 22. Threads 94 on lead screw 88 have exactly the same pitch and the same hand as threads 30 on distal end 26 of housing 22.
Pen body assembly 12 is assembled by placing nut 34 into housing 22 from distal end 26. Clutch assembly 42 then is mounted over splines 39 on nut 34.
Driver 50 is then inserted into proximal end 24 of housing 22, and is urged sufficiently in a distal direction for snap fit engagement with nut 34. In this snapped engagement, the saw teeth of distal clutch 46 will be secured in engagement with teeth 32 of housing 22, and the saw teeth of proximal clutch 44 will be engaged with saw teeth 49 at distal end ~.~5.~ ~Q2 54 of driver 50. Spring 48 will maintain constant selected pressure between these interengaged saw teeth. Insert 78 then is positioned over dose knob 58 such that button 86 of insert 78 is engaged in the axial return track 72 of groove 70 in dose knob 58.
The temporarily assembled insert 78 and dose knob 58 then are urged into housing 22.
Lead screw 88 then is threaded into nut 34, and actuator button 76 is snapped into engagement with proximal end 60 of dose knob 58.
Cartridge assembly 14, shown in Figs. 1 and 6-11, includes a molded housing 100 which extends from proximal end 18 to distal end 20 of cartridge assembly 14, as io noted above. Housing 100 includes a mounting cavity 102 extending inwardly from proximal end 18. Mounting cavity l02 is characterized by an array of internal threads 104 for threaded engagement with external threads 30 on distal end 26 of housing 22.
The distal end of mounting cavity l02 is defined by anti-rotation tabs 106 which are dimensioned to slidably engaged in slots 96 of lead screw 88. Thus, lead screw 88 can ~5 slidably move relative to anti-rotation tabs 106, but is prevented from rotating relative to tabs l06.
Cartridge holder assembly 14, as shown in Figs. 7-11, further includes a medication cartridge 108 securely retained in housing 100 between tabs 106 and distal 2o end 20 of cartridge assembly 14. Medication cartridge 108 includes an open proximal end 110 and a distal end 112 having a pierceable elastomeric seal 114 securely mounted thereto. A cap 116 extends between housing 100 and cartridge 108 for securely and permanently holding medication cartridge 108 in housing l00. A plunger 118 is disposed in sliding fluid tight engagement in cartridge 108. As shown in Figs.
Further forces exerted on the actuator button will cause the mounting means of the pen body to engage the mounting means of the disposable cartridge assembly.
Continued axial forces on the actuator will cause the mounting threads to engage the disposable cartridge assembly and will continue the proximal movement of the driver. The pen s body assembly will be fully but releasably engaged with the disposable cartridge assembly at the same time that the driver is at its proximal extreme position and in condition to begin delivering selected doses of medication from the pen. Doses of medication can be dispensed as needed over time. The disposable cartridge assembly can be removed and discarded when the medication therein has been exhausted, and a to new disposable medication cartridge assembly may be mounted to the pen body assembly as described above.
DESCRIPTION OF THE DRAWINGS
~s Fig. 1 is an exploded perspective view of the medication delivery pen of the subject invention.
Fig. 2 is an exploded perspective view of the pen body assembly of the medication delivery pen shown in Fig. 1.
Fig. 3 is an end view of the housing of the pen body assembly.
zo Fig. 4 is a cross-sectional view of the nut taken along line 4-4 in Fig. 2.
Fig. S is a cross-sectional view of the insert taken along line 5-S in Fig. 2.
Fig. 6 is an end elevational view of the cartridge holder assembly.
Fig. 7 is a longitudinal cross-sectional view of the pen in a first partly assembled condition.
2s Fig. 8 is a cross-sectional view similar to Fig. 7, and showing the pen in a second partly assembled condition.
~- ~~51 ~0~
Fig. 9 is a cross-sectional view similar to Figs. 7 and 8, and showing the pen in a fully assembled condition.
Fig. 10 is a cross-sectional view similar to Fig. 9, and showing the assembled pen in condition to deliver a selected dose of medication.
s Fig. 11 is a cross-sectional view similar to Fig. 10 and showing the pen after delivery of the selected dose.
Fig. 12 is an exploded perspective view of an alternative embodiment of a medication delivery pen of the subject invention.
Fig. 13 is an end elevational view of the cartridge assembly in the medication io delivery pen shown in Fig. 12.
DETAILED DESCRIPTION
A medication delivery pen in accordance with the subject invention is identified is generally by the numeral 10 in Figs. 1 and 7-11. Medication delivery pen 10 includes a reusable pen body assembly 12, a disposable cartridge assembly 14, a needle cannula assembly 16 and a cap 17. Cartridge assembly 14 includes opposed proximal and distal ends 18 and 20 respectively. Proximal end 18 of cartridge assembly 14 is dimensioned and configured to threadedly engage pen body assembly 12, as explained further zo herein. Distal end 20 of cartridge assembly 14 is configured to securely but releasably engage needle cannula assembly 16.
The preferred embodiment of reusable pen body assembly 12 is illustrated in greater detail in Fig. 2. It is understood, however, that variations from this preferred 25 embodiment may be provided, and are considered to be within the scope of the subject invention. Reusable pen body assembly 12 includes a generally cylindrical housing 22 _g_ ~Z ~~ Q02 having opposed proximal and distal ends 24 and 26, and a substantially hollow throughbore 28 extending axially therethrough. An array of external threads 30 extends proximally from distal end 26 for threaded engagement with proximal end 18 of cartridge holder assembly 14. Portions of hollow throughbore 28 of housing adjacent distal end 26 are characterized by an array of clutch teeth 32, shown in Fig. 3, molded therein. Proximal end 24 of housing 22 is characterized by a cut-out 33 formed therein for receiving a window insert 78, as shown in Fig. 5 and explained further herein.
1o Pen body assembly 12 further includes a nut 34 having opposed proximal and distal ends 36 and 38 respectively. Exterior surface regions of nut 34 between proximal and distal ends 36 and 38, shown in Fig. 4, define a plurality of longitudinally extending splines 39. Proximal end 36 of nut 34 is characterized by a plurality of longitudinally extending resilient fingers 40 with enlarged ends that enable ~5 snap engagement of nut 34 into other portions of pen body assembly 12 as explained further herein. Distal end 38 of nut 34 is radially enlarged to limit axial movement of nut 34 into distal end 26 of housing 22. Thus, nut 34 is axially constrained within housing 22. However, the dimensions and configurations of nut 34 and housing permit free relative rotation therebetween.
Pen body assembly 12 further includes a clutch assembly 42 mounted therein.
Clutch assembly 42 includes a proximal clutch 44, a distal clutch 46 and an annular spring 48 biasingly engaged therebetween. Proximal and distal clutches 44 and 46 each are configured for non-rotatable engagement over splines 39 of nut 34. Distal clutch 46 includes an array of distally facing saw teeth dimensioned, disposed and configured for engagement with teeth 32, shown in Fig. 3, on the interior of housing 22, such that ~~ ~~ Q02 distal clutch 46 can rotate only in one direction relative to housing 22.
Proximal clutch 44 includes an array of proximally facing teeth which are also co~gured for unidirectional rotation as explained further herein.
Pen body assembly 12 further includes a generally cylindrical driver 50 having opposed proximal and distal ends 52 and 54. Driver 50 is slidably inserted into housing 22 of pen body assembly 12 such that distal end 54 of driver 50 is snap fit over the enlarged ends of resilient forgers 40 at proximal end 36 of nut 34. This snap fit engagement prevents axial movement between nut 34 and driver 50, but permits free 1o relative rotational movement within housing 22. Distal end 54 of driver 50 is also characterized by an array of saw teeth 49 that engage with the saw teeth on proximal clutch 44. Outer surface regions of driver 50 are characterized by splines 56 extending radially outwardly thereon and along a substantial portion of the length of driver 50.
t5 Pen body assembly 12 further includes a dose, knob 58 which is a hollow generally cylindrical structure having opposed proximal and distal ends 60 and 62 and opposed inner and outer surfaces 64 and 66. Inner surface 64 is characterized by longitudinally extending grooves 68 which are disposed and dimensioned for engagement with splines 56 on driver 50. More particularly, dose knob 58 is spline 2o mounted over driver 50 within housing 22 of pen body assembly 12. Thus, axially extending grooves 68 in dose knob 58 engage splines 56 of driver 50 to prevent relative rotation therebetween, but permitting relative axial movement. Outer surface 66 of dose knob 58 is characterized by a groove 70 that includes a linear component 72 and a helical component 74, which connects opposed ends of linear component 72.
Portions 25 of outer surface 66 adjacent helical component 74 of groove 70 are provided with dosage indicia to define dose amounts corresponding to different positions along groove 2~ ~Z Q02 70 as explained further herein. Proximal end 60 of dose knob S 8 is characterized by a gnarled exterior surface to facilitate manipulation for setting a selected dose. An actuator button 76 is snapped in to engagement with proximal end 60 of dose knob 58 to permit relative rotation therebetween.
An insert 78, shown in Figs. 2 and S, is snapped into engagement with cut-out 33 in the proximal end 24 of housing 22. Insert 78 includes opposed inner and outer surfaces 80 and 82 and a window 84 extending therebetween. Inner surface 80 of insert 78 includes a button 86 on an interior face which is dimensioned and disposed to io engage in groove 70 of dose knob 58. Button 86 and window 84 are disposed to enable the indicia on dose knob 58 to be visible through window 84.
Pen body assembly 12 further includes a lead screw 88 with opposed proximal and distal ends 90 and 92 and an array of external threads 94. External threads 94 are ~5 characterized, however, by a pair of opposed axially extending grooves 96 which extend from distal end 92 substantially to the proximal end 90. Threads 94 are engaged in nut 34, such that proximal end 90 of lead screw 88 is within housing 22 and distal end 92 projects distally beyond housing 22. Threads 94 on lead screw 88 have exactly the same pitch and the same hand as threads 30 on distal end 26 of housing 22.
Pen body assembly 12 is assembled by placing nut 34 into housing 22 from distal end 26. Clutch assembly 42 then is mounted over splines 39 on nut 34.
Driver 50 is then inserted into proximal end 24 of housing 22, and is urged sufficiently in a distal direction for snap fit engagement with nut 34. In this snapped engagement, the saw teeth of distal clutch 46 will be secured in engagement with teeth 32 of housing 22, and the saw teeth of proximal clutch 44 will be engaged with saw teeth 49 at distal end ~.~5.~ ~Q2 54 of driver 50. Spring 48 will maintain constant selected pressure between these interengaged saw teeth. Insert 78 then is positioned over dose knob 58 such that button 86 of insert 78 is engaged in the axial return track 72 of groove 70 in dose knob 58.
The temporarily assembled insert 78 and dose knob 58 then are urged into housing 22.
Lead screw 88 then is threaded into nut 34, and actuator button 76 is snapped into engagement with proximal end 60 of dose knob 58.
Cartridge assembly 14, shown in Figs. 1 and 6-11, includes a molded housing 100 which extends from proximal end 18 to distal end 20 of cartridge assembly 14, as io noted above. Housing 100 includes a mounting cavity 102 extending inwardly from proximal end 18. Mounting cavity l02 is characterized by an array of internal threads 104 for threaded engagement with external threads 30 on distal end 26 of housing 22.
The distal end of mounting cavity l02 is defined by anti-rotation tabs 106 which are dimensioned to slidably engaged in slots 96 of lead screw 88. Thus, lead screw 88 can ~5 slidably move relative to anti-rotation tabs 106, but is prevented from rotating relative to tabs l06.
Cartridge holder assembly 14, as shown in Figs. 7-11, further includes a medication cartridge 108 securely retained in housing 100 between tabs 106 and distal 2o end 20 of cartridge assembly 14. Medication cartridge 108 includes an open proximal end 110 and a distal end 112 having a pierceable elastomeric seal 114 securely mounted thereto. A cap 116 extends between housing 100 and cartridge 108 for securely and permanently holding medication cartridge 108 in housing l00. A plunger 118 is disposed in sliding fluid tight engagement in cartridge 108. As shown in Figs.
7-11, 25 plunger 118 initially is disposed substantially adjacent proximal end 110 of medication cartridge 108. Portions of cartridge 108 between plunger 118 and seal 114 are filled 2~ ~Z 7~2 with a medication 120, such as insulin.
Needle cannula assembly 16 includes a double ended needle cannula 122 having opposed proximal and distal points 124 and 126, respectively, and a lumen extending s axially therebetween. A mounting hub 128 is engaged on needle cannula 122 and is removably engageable with cap 116 of cartridge holder assembly 14. The relative location of mounting hub 128 ensures that proximal point 124 of needle cannula will pierce seal 114 when mounting hub 128 is engaged with cap l16. Needle cannula assembly 16 further includes a shield 130 removably mounted thereon for protecting io against accidental needle sticks until immediately prior to use of pen 10.
As noted above, pen body assembly 12 is reusable, and cartridge holder assembly 14 is disposable. More particularly, cartridge 108 in cartridge holder assembly 14 will contain a volume of medication 120 su~cient for administration of ~5 several doses. After exhaustion of the medication 120, cartridge holder assembly 14 will be threadedly disengaged from pen body assembly 12 and discarded. A new cartridge holder assembly 14 may then be mounted to the reusable pen body assembly 12. To effect the mounting of a new cartridge holder assembly 14 to the reusable pen body assembly 12, the patient need merely align slots 96 at distal end 92 of lead screw 20 88 with tabs 106 at proximal end 18 of cartridge holder assembly 14. Distal end 92 of lead screw 88 is then advanced distally into cartridge holder assembly 14 until distal end 92 of lead screw 88 engages plunger 118, as shown in Fig. 7. Assembly continues by merely exerting axial forces on thumb swivel 76 and on cartridge holder assembly 14. Additionally, friction between plunger 118 and cartridge 108 and fluid forces 25 exerted by medication 120 and seal l14 will prevent axial advancement of lead screw 88 beyond the position depicted in Fig. 9 during assembly. Additionally, the splined 2~~~'~0~
engagement of distal clutch 46 with nut 34 and the engagement of the teeth on distal clutch 46 with the corresponding teeth 32 on housing 22 prevents independent rotation of nut 34 during this initial mounting of reusable pen body assembly 12 with a new disposable cartridge assembly 14. Thus, axial forces exerted on thumb swivel 76 will cause cartridge housing 100 to threadedly advance along threads 94 of lead screw 88.
After sufficient axial advancement, threads 30 at distal end 26 of pen body housing 22 will engage internal threads 104 at proximal end I8 of cartridge holder assembly 14, as shown in Fig. 8. As noted above, external threads 30 at distal end 26 of housing 22 have exactly the same pitch and hand as threads 94 on lead screw 88.
Hence, further axial forces exerted on thumb swivel 76 will cause the simultaneous threaded advancement of housing 22 along Iead screw 88 and into cavity 102 at proximal end 18 of cartridge holder assembly 14. Thus, because of their identical pitches, lead screw 88 will move proximally relative to pen body housing 22, while pen ~5 body housing 22 and cartridge holder assembly 14 are approaching their fully seated and threaded condition depicted in Fig. 9.
The assembled reusable pen body assembly 12 and cartridge assembly 14 may be stored until a selected dose of medication is required. Just prior to use, a needle 2o cannula assembly 16 may be threadedly engaged to distal end 20 of cartridge assembly 14. This threaded engagement will cause proximal tip 124 of needle cannula 122 to pierce seal 114 and provide communication with medication 120. Shield 130 may then be removed.
25 A desired dose of medication 120 may be set by rotating dose knob 58 until indicia corresponding to the desired dose appears in window 84 of insert 78.
The engagement of button 86 on insert 78 in helical portion 74 of groove 70 in dose knob 58 will cause a threaded retraction of dose knob 58 relative to housing 22 of reusable pen body assembly 12. This threaded retraction of dose knob 58 will cause a simultaneous rotation of driver SO splined thereto. However, nut 34 will not rotate because the saw teeth on distal clutch 46 and saw teeth 32 on interior portions of housing 22 are locked to prevent rotation in that direction. Proximal clutch 44 is splined to nut 34, and hence also will not turn. However, saw teeth 49 at distal end 54 of driver SO are shaped to allow rotation relative to proximal clutch 44, but provide an audible click for each unit of medication in the selected dose. This is helpful for io visually impaired patients who may be required to set doses and administer insulin or other medication to themselves. Annular spring 48 contributes to the engagement that provides these audible clicking sounds.
When the desired dose is set, as shown in Fig. 10, injection is achieved by merely pushing on actuator button 76. This causes dose knob 58 to turn about helix 74 relative to pen body housing 22, and driver 50 rotates through the same number of degrees. This rotation is opposite to the rotation generated by the dose setting procedure, and the rotational freedom of the clutch assembly 42 is reversed.
Thus, as driver SO turns the previously clicking proximal clutch 44 is locked to and turns with 2o driver 50. This driving movement of proximal clutch 44 causes a corresponding rotational movement of nut 34 because of the splined engagement therebetween.
Distal clutch 46 is now free to rotate against saw teeth 32 on housing 22, and makes an audible clicking indication during injection of medication.
Rotation of lead screw 88 is prevented by tabs 106 unitarily molded with housing l00 of cartridge holder assembly 14. Therefore, as nut 34 rotates under the ~~51 ~p~
driving action of proximal clutch 44 and driver 50, lead screw 88 will be advanced axially into cartridge holder assembly 14. This axial advancement of lead screw 88 causes distal end 92 thereof to urge plunger l18 distally into cartridge 108, and hence causes medication 120 to be injected through needle cannula 122. Injection will be terminated when proximal end 60 of dose knob 58 engages against proximal end 24 of pen body housing 22, as shown in Fig. 11.
Upon completion of the injection, needle cannula assembly 16 may be disengaged from cartridge holder assembly 14 and safely discarded. Cap 17 may be to mounted over cartridge holder assembly 14, and pen 10 may be stored or carried in a convenient location until the next dose of medication is required. A
subsequent dose of medication will be set in exactly the manner as described above. However, for such a subsequent dose, lead screw 88 and plunger 118 will be in a partly advanced position as a starting point. Dose setting and injections can be carried out until all of medication 120 has been used. Cartridge holder assembly 14 may then be threadedly disengaged from pen body assembly 12, and slidably separated from lead screw 88. The separated cartridge holder assembly may then be discarded and replaced as described above.
Fig. 12 shows an alternative embodiment of a medication delivery pen 200 2o according to the present invention that does not include anti-rotation tabs 106 formed in mounting cavity 102 of cartridge holder assembly I4, like that shown in the medication delivery pen described above. As shown in Figs. 12 and 13, cartridge holder assembly 14 of pen 200 includes a plurality of ribs 210 extending from the proximal end 18 of housing 100 into mounting cavity 102. Ribs 210 are disposed to slide over and prevent z5 rotation of a rotatable disk 220 mounted upon pen body assembly 12. Disk includes a textured circumference 205 such that each rib 210 meshes with a portion of ~~ ~1 ~~2 the textured circumference 205 when cartridge holder assembly 14 is being mounted on pen body assembly 12. Disk 220 also includes a pair of tabs 225 that ride within slots 96 of lead screw 88 to prevent rotation of lead screw 88, when cartridge holder assembly 14 is being mounted on pen body assembly 12. The specific embodiment s shown in Figs. 12 and 13 is merely exemplary, a medication delivery pen according to the present invention could also function with only one slot in lead screw 88 for receiving only one tab 225. Likewise, it is not necessary for lead screw 88 to have a slot or disk 220 to have a tab, since lead screw 88 could merely have a flat portion extending along its side for mating with a flat portion within a hole in disk 220. All to these variations would provide the benefits of the present invention and, more particularly, eliminate the need for slots 96 in distal end 92 of lead screw 88 and tabs 106 in proximal end 18 of housing 100 which would therefore permit standard medication cartridges to be used with the medication delivery pen.
is While the invention has been described with respect to a preferred embodiment, it is apparent that various changes can be made without departing from the scope of the invention as defined by the appended claims. In particular, the reusable pen body assembly may have other driving and/or clutch mechanisms. Additionally, different means for preventing and/or enabling rotation during the dose setting and injection 2o phases may be provided. Similarly, other means for mounting needle cannula to the cartridge assembly may be provided. These various optional constructions will be apparent to those skilled in the art after having read the subject disclosure.
Needle cannula assembly 16 includes a double ended needle cannula 122 having opposed proximal and distal points 124 and 126, respectively, and a lumen extending s axially therebetween. A mounting hub 128 is engaged on needle cannula 122 and is removably engageable with cap 116 of cartridge holder assembly 14. The relative location of mounting hub 128 ensures that proximal point 124 of needle cannula will pierce seal 114 when mounting hub 128 is engaged with cap l16. Needle cannula assembly 16 further includes a shield 130 removably mounted thereon for protecting io against accidental needle sticks until immediately prior to use of pen 10.
As noted above, pen body assembly 12 is reusable, and cartridge holder assembly 14 is disposable. More particularly, cartridge 108 in cartridge holder assembly 14 will contain a volume of medication 120 su~cient for administration of ~5 several doses. After exhaustion of the medication 120, cartridge holder assembly 14 will be threadedly disengaged from pen body assembly 12 and discarded. A new cartridge holder assembly 14 may then be mounted to the reusable pen body assembly 12. To effect the mounting of a new cartridge holder assembly 14 to the reusable pen body assembly 12, the patient need merely align slots 96 at distal end 92 of lead screw 20 88 with tabs 106 at proximal end 18 of cartridge holder assembly 14. Distal end 92 of lead screw 88 is then advanced distally into cartridge holder assembly 14 until distal end 92 of lead screw 88 engages plunger 118, as shown in Fig. 7. Assembly continues by merely exerting axial forces on thumb swivel 76 and on cartridge holder assembly 14. Additionally, friction between plunger 118 and cartridge 108 and fluid forces 25 exerted by medication 120 and seal l14 will prevent axial advancement of lead screw 88 beyond the position depicted in Fig. 9 during assembly. Additionally, the splined 2~~~'~0~
engagement of distal clutch 46 with nut 34 and the engagement of the teeth on distal clutch 46 with the corresponding teeth 32 on housing 22 prevents independent rotation of nut 34 during this initial mounting of reusable pen body assembly 12 with a new disposable cartridge assembly 14. Thus, axial forces exerted on thumb swivel 76 will cause cartridge housing 100 to threadedly advance along threads 94 of lead screw 88.
After sufficient axial advancement, threads 30 at distal end 26 of pen body housing 22 will engage internal threads 104 at proximal end I8 of cartridge holder assembly 14, as shown in Fig. 8. As noted above, external threads 30 at distal end 26 of housing 22 have exactly the same pitch and hand as threads 94 on lead screw 88.
Hence, further axial forces exerted on thumb swivel 76 will cause the simultaneous threaded advancement of housing 22 along Iead screw 88 and into cavity 102 at proximal end 18 of cartridge holder assembly 14. Thus, because of their identical pitches, lead screw 88 will move proximally relative to pen body housing 22, while pen ~5 body housing 22 and cartridge holder assembly 14 are approaching their fully seated and threaded condition depicted in Fig. 9.
The assembled reusable pen body assembly 12 and cartridge assembly 14 may be stored until a selected dose of medication is required. Just prior to use, a needle 2o cannula assembly 16 may be threadedly engaged to distal end 20 of cartridge assembly 14. This threaded engagement will cause proximal tip 124 of needle cannula 122 to pierce seal 114 and provide communication with medication 120. Shield 130 may then be removed.
25 A desired dose of medication 120 may be set by rotating dose knob 58 until indicia corresponding to the desired dose appears in window 84 of insert 78.
The engagement of button 86 on insert 78 in helical portion 74 of groove 70 in dose knob 58 will cause a threaded retraction of dose knob 58 relative to housing 22 of reusable pen body assembly 12. This threaded retraction of dose knob 58 will cause a simultaneous rotation of driver SO splined thereto. However, nut 34 will not rotate because the saw teeth on distal clutch 46 and saw teeth 32 on interior portions of housing 22 are locked to prevent rotation in that direction. Proximal clutch 44 is splined to nut 34, and hence also will not turn. However, saw teeth 49 at distal end 54 of driver SO are shaped to allow rotation relative to proximal clutch 44, but provide an audible click for each unit of medication in the selected dose. This is helpful for io visually impaired patients who may be required to set doses and administer insulin or other medication to themselves. Annular spring 48 contributes to the engagement that provides these audible clicking sounds.
When the desired dose is set, as shown in Fig. 10, injection is achieved by merely pushing on actuator button 76. This causes dose knob 58 to turn about helix 74 relative to pen body housing 22, and driver 50 rotates through the same number of degrees. This rotation is opposite to the rotation generated by the dose setting procedure, and the rotational freedom of the clutch assembly 42 is reversed.
Thus, as driver SO turns the previously clicking proximal clutch 44 is locked to and turns with 2o driver 50. This driving movement of proximal clutch 44 causes a corresponding rotational movement of nut 34 because of the splined engagement therebetween.
Distal clutch 46 is now free to rotate against saw teeth 32 on housing 22, and makes an audible clicking indication during injection of medication.
Rotation of lead screw 88 is prevented by tabs 106 unitarily molded with housing l00 of cartridge holder assembly 14. Therefore, as nut 34 rotates under the ~~51 ~p~
driving action of proximal clutch 44 and driver 50, lead screw 88 will be advanced axially into cartridge holder assembly 14. This axial advancement of lead screw 88 causes distal end 92 thereof to urge plunger l18 distally into cartridge 108, and hence causes medication 120 to be injected through needle cannula 122. Injection will be terminated when proximal end 60 of dose knob 58 engages against proximal end 24 of pen body housing 22, as shown in Fig. 11.
Upon completion of the injection, needle cannula assembly 16 may be disengaged from cartridge holder assembly 14 and safely discarded. Cap 17 may be to mounted over cartridge holder assembly 14, and pen 10 may be stored or carried in a convenient location until the next dose of medication is required. A
subsequent dose of medication will be set in exactly the manner as described above. However, for such a subsequent dose, lead screw 88 and plunger 118 will be in a partly advanced position as a starting point. Dose setting and injections can be carried out until all of medication 120 has been used. Cartridge holder assembly 14 may then be threadedly disengaged from pen body assembly 12, and slidably separated from lead screw 88. The separated cartridge holder assembly may then be discarded and replaced as described above.
Fig. 12 shows an alternative embodiment of a medication delivery pen 200 2o according to the present invention that does not include anti-rotation tabs 106 formed in mounting cavity 102 of cartridge holder assembly I4, like that shown in the medication delivery pen described above. As shown in Figs. 12 and 13, cartridge holder assembly 14 of pen 200 includes a plurality of ribs 210 extending from the proximal end 18 of housing 100 into mounting cavity 102. Ribs 210 are disposed to slide over and prevent z5 rotation of a rotatable disk 220 mounted upon pen body assembly 12. Disk includes a textured circumference 205 such that each rib 210 meshes with a portion of ~~ ~1 ~~2 the textured circumference 205 when cartridge holder assembly 14 is being mounted on pen body assembly 12. Disk 220 also includes a pair of tabs 225 that ride within slots 96 of lead screw 88 to prevent rotation of lead screw 88, when cartridge holder assembly 14 is being mounted on pen body assembly 12. The specific embodiment s shown in Figs. 12 and 13 is merely exemplary, a medication delivery pen according to the present invention could also function with only one slot in lead screw 88 for receiving only one tab 225. Likewise, it is not necessary for lead screw 88 to have a slot or disk 220 to have a tab, since lead screw 88 could merely have a flat portion extending along its side for mating with a flat portion within a hole in disk 220. All to these variations would provide the benefits of the present invention and, more particularly, eliminate the need for slots 96 in distal end 92 of lead screw 88 and tabs 106 in proximal end 18 of housing 100 which would therefore permit standard medication cartridges to be used with the medication delivery pen.
is While the invention has been described with respect to a preferred embodiment, it is apparent that various changes can be made without departing from the scope of the invention as defined by the appended claims. In particular, the reusable pen body assembly may have other driving and/or clutch mechanisms. Additionally, different means for preventing and/or enabling rotation during the dose setting and injection 2o phases may be provided. Similarly, other means for mounting needle cannula to the cartridge assembly may be provided. These various optional constructions will be apparent to those skilled in the art after having read the subject disclosure.
Claims (6)
1. A medication delivery pen comprising:
a disposable medication-containing cartridge having a plunger in sliding fluid tight engagement within said cartridge;
a cartridge assembly for holding said cartridge and having opposed proximal and distal ends with said proximal end having an array of threads;
a reusable pen body assembly for mounting on said cartridge assembly and including a housing with opposed proximal and distal ends, said distal end having an array of threads dimensioned and having a pitch for threaded engagement with said array of threads at said proximal end of said cartridge assembly;
a lead screw having a proximal end disposed in said housing and a distal end projecting beyond said distal end of said housing for selective engagement with said plunger to push said plunger in said distal direction, said lead screw having a plurality of threads extending between said proximal end and said distal end of said lead screw and having a pitch substantially equal to said pitch of said array of threads at said distal end of said housing; and anti-rotation means for preventing relative rotation between said lead screw and said housing when said housing is being threaded to said cartridge assembly, whereby said lead screw moves in a distal direction in said cartridge assembly as said housing is threadedly moved in a distal direction into said cartridge assembly, said anti-rotation means comprising:
a rotatable disk having a textured circumference that is mounted at said distal end of said housing to rotate with said lead screw;
and a plurality of ribs in said cartridge assembly for mating with said textured circumference of said disk to prevent rotation of said lead screw when said housing is threaded to said cartridge assembly.
a disposable medication-containing cartridge having a plunger in sliding fluid tight engagement within said cartridge;
a cartridge assembly for holding said cartridge and having opposed proximal and distal ends with said proximal end having an array of threads;
a reusable pen body assembly for mounting on said cartridge assembly and including a housing with opposed proximal and distal ends, said distal end having an array of threads dimensioned and having a pitch for threaded engagement with said array of threads at said proximal end of said cartridge assembly;
a lead screw having a proximal end disposed in said housing and a distal end projecting beyond said distal end of said housing for selective engagement with said plunger to push said plunger in said distal direction, said lead screw having a plurality of threads extending between said proximal end and said distal end of said lead screw and having a pitch substantially equal to said pitch of said array of threads at said distal end of said housing; and anti-rotation means for preventing relative rotation between said lead screw and said housing when said housing is being threaded to said cartridge assembly, whereby said lead screw moves in a distal direction in said cartridge assembly as said housing is threadedly moved in a distal direction into said cartridge assembly, said anti-rotation means comprising:
a rotatable disk having a textured circumference that is mounted at said distal end of said housing to rotate with said lead screw;
and a plurality of ribs in said cartridge assembly for mating with said textured circumference of said disk to prevent rotation of said lead screw when said housing is threaded to said cartridge assembly.
2. The medication delivery pen of claim 1, wherein said pen body assembly further includes driver means for driving said lead screw into said cartridge assembly and an actuator button rotatably mounted on said driver means, such that axial forces exerted on said actuator button simultaneously generate movement of said lead screw distally into said cartridge assembly.
3. The medication delivery pen of claim 1, wherein said cartridge assembly defines a mounting cavity adjacent said proximal end thereof, said plurality of threads of said cartridge assembly defining internal threads in said mounting cavity, said distal end of said housing being dimensioned for threaded engagement in said mounting cavity of said cartridge assembly.
4. The medication delivery pen of claim 1, wherein said pen body assembly comprises dose setting means for defining specified distances of travel for said lead screw corresponding to selected doses of medication to be delivered.
5. The medication delivery pen of claim 1, wherein said cartridge further comprises a sealed end having a pierceable elastomeric seal, said cartridge assembly further comprises needle mounting means at said distal end, and said medication delivery pen further comprises a needle cannula assembly having;
a hub selectively engageable with said mounting means of said cartridge assembly and a double-ended needle having opposed proximal and distal points, said proximal point of said needle being dimensioned and disposed to pierce said seal upon engagement with said cartridge.
a hub selectively engageable with said mounting means of said cartridge assembly and a double-ended needle having opposed proximal and distal points, said proximal point of said needle being dimensioned and disposed to pierce said seal upon engagement with said cartridge.
6. The medication delivery pen of claim 1, wherein:
said rotatable disk includes a hole for receiving said lead screw and at least one tab extending into said hole; and said lead screw further includes at least one slot extending axially along said lead screw for receiving said tab to prevent rotation of said lead screw when said plurality of ribs axe mated with said rotatable disk.
said rotatable disk includes a hole for receiving said lead screw and at least one tab extending into said hole; and said lead screw further includes at least one slot extending axially along said lead screw for receiving said tab to prevent rotation of said lead screw when said plurality of ribs axe mated with said rotatable disk.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26359194A | 1994-06-22 | 1994-06-22 | |
| US08/263,591 | 1994-06-22 | ||
| US08/314,179 US5725508A (en) | 1994-06-22 | 1994-09-28 | Quick connect medication delivery pen |
| US08/314,179 | 1994-09-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2151702A1 CA2151702A1 (en) | 1995-12-23 |
| CA2151702C true CA2151702C (en) | 1999-08-03 |
Family
ID=26949948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002151702A Expired - Fee Related CA2151702C (en) | 1994-06-22 | 1995-06-13 | Quick connect medication delivery pen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5725508A (en) |
| EP (1) | EP0688571B1 (en) |
| JP (1) | JP2689372B2 (en) |
| CA (1) | CA2151702C (en) |
| DE (1) | DE69522268T2 (en) |
| ES (1) | ES2161831T3 (en) |
Families Citing this family (125)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5674204A (en) * | 1995-09-19 | 1997-10-07 | Becton Dickinson And Company | Medication delivery pen cap actuated dose delivery clutch |
| US5688251A (en) * | 1995-09-19 | 1997-11-18 | Becton Dickinson And Company | Cartridge loading and priming mechanism for a pen injector |
| US6277101B1 (en) | 1996-04-02 | 2001-08-21 | Disetronic Licensing Ag | Injection device |
| WO1997036626A1 (en) * | 1996-04-02 | 1997-10-09 | Disetronic Licensing Ag | Injection device |
| WO1998001172A1 (en) * | 1996-07-05 | 1998-01-15 | Disetronic Licensing Ag | Injection device for injection of liquid |
| US6110149A (en) * | 1996-09-13 | 2000-08-29 | Novo Nordisk A/S | Syringe |
| DE19717107B4 (en) | 1997-04-23 | 2005-06-23 | Disetronic Licensing Ag | System of container and drive device for a piston, which is held in the container containing a drug fluid |
| WO1998048528A1 (en) * | 1997-04-24 | 1998-10-29 | Ntt Mobile Communications Network Inc. | Mobile communication method and mobile communication system |
| DE19723647C1 (en) | 1997-06-05 | 1998-12-24 | Disetronic Licensing Ag | Fluid dosing unit indicator for e.g. insulin or for pipetting laboratory fluids |
| EP1015050A1 (en) * | 1997-07-11 | 2000-07-05 | Novo Nordisk A/S | An apparatus for the registration of the setting of a medical device |
| US5921966A (en) * | 1997-08-11 | 1999-07-13 | Becton Dickinson And Company | Medication delivery pen having an improved clutch assembly |
| DE19740187C1 (en) * | 1997-09-12 | 1999-04-15 | Disetronic Licensing Ag | Dosing unit, e.g. for medicines |
| WO1999016485A1 (en) | 1997-09-29 | 1999-04-08 | Becton Dickinson And Company | Injection device and drug cartridge for preventing cross-use of the device and drug cartridge |
| DE19755125B4 (en) | 1997-12-11 | 2006-04-20 | Tecpharma Licensing Ag | Needle protection device for injection devices |
| BR9906857A (en) * | 1998-01-30 | 2000-11-14 | Novo Nordisk As | Injection syringes |
| US6221053B1 (en) * | 1998-02-20 | 2001-04-24 | Becton, Dickinson And Company | Multi-featured medication delivery pen |
| DE19821933C1 (en) * | 1998-05-15 | 1999-11-11 | Disetronic Licensing Ag | Device for administering an injectable product |
| US6290679B1 (en) | 1999-05-14 | 2001-09-18 | Disetronic Licensing Ag | Device for metered administration of an injectable product |
| DE19822031C2 (en) | 1998-05-15 | 2000-03-23 | Disetronic Licensing Ag | Auto injection device |
| JP2002520098A (en) | 1998-07-08 | 2002-07-09 | ノボ ノルディスク アクティーゼルスカブ | Drug release device and cartridge assembly used therein |
| EP1094857B1 (en) * | 1998-07-08 | 2003-10-08 | Novo Nordisk A/S | A medical delivery device and a cartridge assembly for use in the same |
| FR2783433B1 (en) * | 1998-09-18 | 2001-02-16 | Delab | SYRINGES FOR THE ADMINISTRATION OF PASTY OR SEMI-SOLID FORMULATIONS |
| US6192891B1 (en) * | 1999-04-26 | 2001-02-27 | Becton Dickinson And Company | Integrated system including medication delivery pen, blood monitoring device, and lancer |
| ES2258469T3 (en) * | 1999-08-05 | 2006-09-01 | Becton Dickinson And Company | MEDICATION ADMINISTRATION PENCIL. |
| TW453884B (en) | 1999-09-16 | 2001-09-11 | Novo Nordisk As | Dose setting limiter |
| US6673035B1 (en) | 1999-10-22 | 2004-01-06 | Antares Pharma, Inc. | Medical injector and medicament loading system for use therewith |
| WO2001054757A1 (en) * | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | A dose setting limiter |
| US6663602B2 (en) | 2000-06-16 | 2003-12-16 | Novo Nordisk A/S | Injection device |
| WO2002009797A1 (en) * | 2000-08-02 | 2002-02-07 | Becton Dickinson And Company | Pen needle and safety shield system |
| US6986760B2 (en) * | 2000-08-02 | 2006-01-17 | Becton, Dickinson And Company | Pen needle and safety shield system |
| NL1016298C2 (en) * | 2000-09-29 | 2002-04-03 | Sgt Exploitatie Bv | Vial, method for using a vial for analysis on a sample, as well as a system for performing the method according to the invention using a vial according to the invention. |
| US6899699B2 (en) | 2001-01-05 | 2005-05-31 | Novo Nordisk A/S | Automatic injection device with reset feature |
| DE10163328B4 (en) * | 2001-07-30 | 2005-08-11 | Tecpharma Licensing Ag | Administration device with anti-rotation device |
| DE10163327A1 (en) | 2001-07-30 | 2003-02-27 | Disetronic Licensing Ag | Reservoir module with piston rod |
| US20040098010A1 (en) * | 2001-10-22 | 2004-05-20 | Glenn Davison | Confuser crown skin pricker |
| GB0201689D0 (en) | 2002-01-25 | 2002-03-13 | Dca Design Consultants Ltd | Improvements in and relating to a medicament injection device |
| JP3993169B2 (en) | 2002-02-11 | 2007-10-17 | アンタレス・ファーマ・インコーポレーテッド | Intradermal syringe |
| US7844346B2 (en) | 2002-05-23 | 2010-11-30 | Biocontrol Medical Ltd. | Electrode assembly for nerve control |
| EP1545663B1 (en) * | 2002-10-01 | 2006-08-30 | Becton Dickinson and Company | Medication delivery pen |
| GB0304822D0 (en) * | 2003-03-03 | 2003-04-09 | Dca Internat Ltd | Improvements in and relating to a pen-type injector |
| US9205197B2 (en) * | 2003-03-03 | 2015-12-08 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device dose setting mechanism |
| GB0308267D0 (en) * | 2003-04-10 | 2003-05-14 | Dca Design Int Ltd | Improvements in and relating to a pen-type injector |
| US20040253281A1 (en) * | 2003-06-12 | 2004-12-16 | Atrium Medical Corp. | Therapeutic markings applied to tissue |
| US8932264B2 (en) * | 2003-08-11 | 2015-01-13 | Becton, Dickinson And Company | Medication delivery pen assembly with needle locking safety shield |
| DE102004006411B4 (en) | 2004-02-09 | 2018-09-20 | Volkswagen Ag | Method and device for providing fastening means arranged in a loading device in a specific orientation |
| US20050261639A1 (en) * | 2004-05-05 | 2005-11-24 | Atrium Medical Corp. | Medicated ink marker |
| US20050251152A1 (en) * | 2004-05-05 | 2005-11-10 | Atrium Medical Corp. | Illuminated medicated ink marker |
| JP2008516709A (en) | 2004-10-21 | 2008-05-22 | ノボ・ノルデイスク・エー／エス | Drug delivery system with detector of signal indicative of released dosage |
| US10383996B2 (en) | 2004-10-21 | 2019-08-20 | Novo Nordisk A/S | Injection device with a processor for collecting ejection information |
| CA2584760C (en) | 2004-10-21 | 2013-12-24 | Novo Nordisk A/S | Dial-down mechanism for wind-up pen |
| PL1819382T3 (en) * | 2004-10-21 | 2010-03-31 | Novo Nordisk As | Injection device with torsion spring and rotatable display |
| DK1850892T4 (en) | 2005-01-24 | 2023-06-06 | Antares Pharma Inc | Prefilled needle-assisted syringe injector |
| BRPI0607012A2 (en) | 2005-01-25 | 2009-12-01 | Novo Nordisk As | injection device |
| WO2006089768A1 (en) * | 2005-02-28 | 2006-08-31 | Novo Nordisk A/S | A dose setting mechanism for an injection device |
| WO2006114396A1 (en) | 2005-04-24 | 2006-11-02 | Novo Nordisk A/S | Injection device |
| GB0524604D0 (en) * | 2005-12-02 | 2006-01-11 | Owen Mumford Ltd | Injection method and apparatus |
| GB2434103B (en) * | 2006-01-12 | 2009-11-25 | Owen Mumford Ltd | Lancet firing device |
| WO2007104636A1 (en) * | 2006-03-10 | 2007-09-20 | Novo Nordisk A/S | An injection device and a method of changing a cartridge in the device |
| CN101400394B (en) * | 2006-03-10 | 2012-07-04 | 诺沃-诺迪斯克有限公司 | An injection device having a gearing arrangement |
| RU2459247C2 (en) | 2006-03-20 | 2012-08-20 | Ново Нордиск А/С | Electronic module for mechanical device for administering medical drugs |
| US8251947B2 (en) | 2006-05-03 | 2012-08-28 | Antares Pharma, Inc. | Two-stage reconstituting injector |
| WO2007132526A1 (en) * | 2006-05-16 | 2007-11-22 | Rorze Corporation | Shuttle type conveying device, microplate feeding and collecting device, pickup device for microplate, cassette for microplate, and shelf for receiving microplate |
| DE602007004972D1 (en) | 2006-05-16 | 2010-04-08 | Novo Nordisk As | GEARING MECHANISM FOR AN INJECTION DEVICE |
| DK2023982T3 (en) * | 2006-05-18 | 2012-10-01 | Novo Nordisk As | Injection device with mode locking means |
| DE102007002096A1 (en) | 2007-01-09 | 2008-07-10 | B. Braun Melsungen Ag | Device for injecting liquids |
| US7384414B1 (en) | 2007-01-23 | 2008-06-10 | Becton, Dickinson And Company | Safety pen needle with non-injection end passive safety features |
| US7462168B2 (en) * | 2007-01-23 | 2008-12-09 | Becton, Dickinson And Company | Safety pen needle with passive safety shield system |
| US7462169B2 (en) * | 2007-01-23 | 2008-12-09 | Becton, Dickinson And Company | Safety shield system for an injection pen needle |
| PL2109474T5 (en) | 2007-02-05 | 2019-07-31 | Novo Nordisk A/S | Injection button |
| BRPI0809265A2 (en) * | 2007-03-23 | 2014-10-07 | Novo Nordisk As | INJECTION DEVICE INCLUDING A TIGHTENING NUT |
| DE102007018696A1 (en) | 2007-04-18 | 2008-10-23 | Sanofi-Aventis Deutschland Gmbh | Injection device for dispensing a medicament |
| EP2234661B1 (en) * | 2007-12-20 | 2013-04-17 | Novo Nordisk A/S | Injection device for delivering a fixed dose of liquid drug |
| CN101977645B (en) | 2008-04-10 | 2013-01-30 | 松下电器产业株式会社 | Medication administering device |
| KR101551210B1 (en) | 2008-05-02 | 2015-09-08 | 사노피-아벤티스 도이칠란트 게엠베하 | Medication delivery device |
| PL2274030T5 (en) * | 2008-05-02 | 2021-08-30 | Sanofi-Aventis Deutschland Gmbh | Medication delivery device |
| EP2318075B1 (en) | 2008-08-05 | 2019-05-22 | Antares Pharma, Inc. | Multiple dosage injector |
| GB2465390A (en) | 2008-11-17 | 2010-05-19 | Owen Mumford Ltd | Syringe needle cover remover |
| US8366680B2 (en) | 2008-12-12 | 2013-02-05 | Sanofi-Aventis Deutschland Gmbh | Resettable drive mechanism for a medication delivery device and medication delivery device |
| SG172114A1 (en) * | 2008-12-12 | 2011-07-28 | Sanofi Aventis Deutschland | Resettable drive mechanism for a medication delivery device and medication delivery device |
| EP2196232A1 (en) * | 2008-12-12 | 2010-06-16 | Sanofi-Aventis Deutschland GmbH | Drive mechanism for a medication delivery device and medication delivery device |
| CA2755779C (en) | 2009-03-20 | 2015-11-10 | Antares Pharma, Inc. | Hazardous agent injection system |
| US8672896B2 (en) * | 2009-06-01 | 2014-03-18 | Sanofi-Aventis Deutschland Gmbh | Inner housing for a drug delivery device |
| CN102481405B (en) * | 2009-09-21 | 2014-06-18 | 诺沃—诺迪斯克有限公司 | Drug delivery system and device with cap function |
| US9463278B2 (en) * | 2009-09-30 | 2016-10-11 | Sanofi-Aventis Deutschland Gmbh | Resettable drive mechanism for a drug delivery device with guide track and blocking means |
| EP2482897B1 (en) * | 2009-09-30 | 2016-02-17 | Sanofi-Aventis Deutschland GmbH | Assembly and piston rod for a drug delivery device |
| WO2011039233A1 (en) * | 2009-09-30 | 2011-04-07 | Sanofi-Aventis Deutschland Gmbh | Injection device |
| EP3733231B1 (en) * | 2009-12-01 | 2021-12-29 | Becton, Dickinson and Company | Injection pen with dial back and last dose control |
| EP2351591A1 (en) * | 2010-02-02 | 2011-08-03 | Sanofi-Aventis Deutschland GmbH | Assembly for a drug delivery device and drug delivery device |
| GB201004626D0 (en) | 2010-03-19 | 2010-05-05 | Owen Mumford Ltd | Improved injection device |
| JP5876039B2 (en) * | 2010-06-11 | 2016-03-02 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Drive mechanism for drug delivery device and drug delivery device |
| EP2579921B1 (en) * | 2010-06-11 | 2018-05-16 | Sanofi-Aventis Deutschland GmbH | Drive mechanism for a drug delivery device |
| DK2579924T3 (en) | 2010-06-11 | 2018-12-10 | Sanofi Aventis Deutschland | DRIVE DEVICE FOR A MEDICINAL DISPENSER AND MEDICINE DISPENSER |
| EP2579927B1 (en) * | 2010-06-11 | 2018-02-21 | Sanofi-Aventis Deutschland GmbH | Drive mechanism for a drug delivery device and drug delivery device |
| JP2013528086A (en) * | 2010-06-11 | 2013-07-08 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Assembly for drug delivery device and drug delivery device |
| NO2579928T3 (en) | 2010-06-11 | 2018-03-10 | ||
| US8246571B2 (en) * | 2010-08-24 | 2012-08-21 | Warsaw Orthopedic, Inc. | Drug storage and delivery device having a retaining member |
| MX2013003340A (en) | 2010-09-24 | 2013-12-02 | Claus Schmidt Moeller | A gearing mechanism for a dose delivery device. |
| ES2543439T3 (en) * | 2011-03-25 | 2015-08-19 | Sanofi-Aventis Deutschland Gmbh | Dose adjustment mechanism and injection device |
| US8496619B2 (en) | 2011-07-15 | 2013-07-30 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
| US9220660B2 (en) | 2011-07-15 | 2015-12-29 | Antares Pharma, Inc. | Liquid-transfer adapter beveled spike |
| BR112014016148A8 (en) | 2011-12-29 | 2017-07-04 | Novo Nordisk As | augmentation / reduction mechanism for automatic injection device and torsion spring-based automatic injection device |
| US8834449B2 (en) | 2012-01-23 | 2014-09-16 | Ikomed Technologies, Inc. | Mixing syringe |
| US9751056B2 (en) | 2012-01-23 | 2017-09-05 | Merit Medical Systems, Inc. | Mixing syringe |
| EP2833944A4 (en) | 2012-04-06 | 2016-05-25 | Antares Pharma Inc | Needle assisted jet injection administration of testosterone compositions |
| WO2013169800A1 (en) | 2012-05-07 | 2013-11-14 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
| PT2953667T (en) | 2013-02-11 | 2020-01-28 | Antares Pharma Inc | Needle assisted jet injection device having reduced trigger force |
| US9707354B2 (en) | 2013-03-11 | 2017-07-18 | Antares Pharma, Inc. | Multiple dosage injector with rack and pinion dosage system |
| RU2535601C1 (en) * | 2013-07-22 | 2014-12-20 | ООО "Уральский центр биофармацевтических технологий" | Syringe handle device |
| EP2851821A1 (en) | 2013-09-20 | 2015-03-25 | Sanofi-Aventis Deutschland GmbH | Medical device and method operating same |
| EP3068469B1 (en) | 2013-11-15 | 2019-02-13 | Sanofi-Aventis Deutschland GmbH | Assembly for a drug delivery device and drug delivery device |
| US9764122B2 (en) | 2014-07-25 | 2017-09-19 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having an occluding member |
| US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
| WO2016061062A1 (en) * | 2014-10-13 | 2016-04-21 | The Werc Shop, LLC | Metered dosing method and mechanisms thereof |
| MA41101A (en) | 2014-12-03 | 2017-10-10 | Lilly Co Eli | AUTOMATIC DRUG INJECTION DEVICE WITH AUDIBLE INDICATION OF INJECTION PROGRESS |
| US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
| EP3187213A1 (en) * | 2015-12-29 | 2017-07-05 | Galderma S.A. | Syringe with click mechanism |
| EP3187217A1 (en) * | 2015-12-29 | 2017-07-05 | Galderma S.A. | Syringe with click mechanism |
| USD802755S1 (en) | 2016-06-23 | 2017-11-14 | Warsaw Orthopedic, Inc. | Drug pellet cartridge |
| US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
| KR20200044016A (en) | 2017-08-24 | 2020-04-28 | 노보 노르디스크 에이/에스 | GLP-1 composition and use |
| US11801350B2 (en) | 2017-12-04 | 2023-10-31 | Arash Anthony Rassouli | Quick-connect syringe and needle system |
| RU2680934C1 (en) * | 2017-12-04 | 2019-02-28 | Общество с ограниченной ответственностью "АйВиФарма" | Pen-type injector for the administration of a solution of a recombinant human follicle-stimulating hormone |
| WO2020102781A1 (en) * | 2018-11-16 | 2020-05-22 | Tync, Llc | Device for dispensing essential oil or tincture |
| USD1011914S1 (en) | 2019-11-15 | 2024-01-23 | Tync, Llc | Dispenser for essential oil |
| JP7132441B2 (en) | 2020-02-18 | 2022-09-06 | ノヴォ ノルディスク アー／エス | GLP-1 compositions and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4592745A (en) * | 1984-02-29 | 1986-06-03 | Novo Industri A/S | Dispenser |
| DE3645245C2 (en) * | 1986-11-14 | 1994-01-27 | Haselmeier Wilhelm Fa | Injection appliance |
| US4973318A (en) * | 1988-02-10 | 1990-11-27 | D.C.P. Af 1988 A/S | Disposable syringe |
| US5226896A (en) * | 1990-04-04 | 1993-07-13 | Eli Lilly And Company | Dose indicating injection pen |
| US5279585A (en) * | 1992-02-04 | 1994-01-18 | Becton, Dickinson And Company | Medication delivery pen having improved dose delivery features |
| US5549575A (en) * | 1994-09-13 | 1996-08-27 | Becton Dickinson And Company | Cartridge retainer assembly for medication delivery pen |
-
1994
- 1994-09-28 US US08/314,179 patent/US5725508A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 ES ES95303894T patent/ES2161831T3/en not_active Expired - Lifetime
- 1995-06-07 DE DE69522268T patent/DE69522268T2/en not_active Expired - Lifetime
- 1995-06-07 EP EP95303894A patent/EP0688571B1/en not_active Expired - Lifetime
- 1995-06-13 CA CA002151702A patent/CA2151702C/en not_active Expired - Fee Related
- 1995-06-20 JP JP7153143A patent/JP2689372B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08730A (en) | 1996-01-09 |
| CA2151702A1 (en) | 1995-12-23 |
| ES2161831T3 (en) | 2001-12-16 |
| EP0688571B1 (en) | 2001-08-22 |
| EP0688571A1 (en) | 1995-12-27 |
| US5725508A (en) | 1998-03-10 |
| JP2689372B2 (en) | 1997-12-10 |
| DE69522268T2 (en) | 2002-05-02 |
| DE69522268D1 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2151702C (en) | Quick connect medication delivery pen | |
| US5827232A (en) | Quick connect medication delivery pen | |
| EP0861101B1 (en) | Medication delivery pen with cap actuated dose delivery clutch | |
| EP0862473B1 (en) | Pen injector with cartridge loading mechanism | |
| EP0702970B1 (en) | Medication delivery pen with variable increment dose scale | |
| US5944700A (en) | Adjustable injection length pen needle | |
| US7169132B2 (en) | Medication delivery pen | |
| US5921966A (en) | Medication delivery pen having an improved clutch assembly | |
| EP0554995B1 (en) | Reusable medication delivery pen | |
| CA2448726C (en) | Medication dispensing apparatus configured for rotate to prime and pull/push to inject functionality | |
| US6090082A (en) | Vial retainer interface to a medication delivery pen | |
| EP0937472B1 (en) | Repeat-dose medication delivery pen | |
| EP0903156A2 (en) | Pen needle assembly | |
| JP2008511355A (en) | Method for assembling drug delivery device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20140613 |